{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T11:11:42Z","timestamp":1786792302169,"version":"build-2736575974"},"reference-count":53,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"am","delay-in-days":302,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.cpcardiol.2024.102580","type":"journal-article","created":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T14:10:27Z","timestamp":1713708627000},"page":"102580","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Electrocardiographic abnormalities in patients with metabolic dysfunction-associated steatotic liver disease: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0064-0126","authenticated-orcid":false,"given":"Christian Akem","family":"Dimala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nso","family":"Nso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremiah","family":"Wasserlauf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basile","family":"Njei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.cpcardiol.2024.102580_bib0001","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1 Suppl","key":"10.1016\/j.cpcardiol.2024.102580_bib0002","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.cpcardiol.2024.102580_bib0003","first-page":"921","article-title":"NAFLD and cardiovascular diseases: a clinical review","volume":"110","author":"Kasper","year":"2021","journal-title":"Clin Res Cardiol Off J Ger Card Soc"},{"issue":"9","key":"10.1016\/j.cpcardiol.2024.102580_bib0004","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","article-title":"NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications","volume":"69","author":"Targher","year":"2020","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.cpcardiol.2024.102580_bib0005","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S2213-8587(14)70032-4","article-title":"Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome","volume":"2","author":"Yki-J\u00e4rvinen","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"10.1016\/j.cpcardiol.2024.102580_bib0006","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.2337\/dc16-0091","article-title":"Nonalcoholic fatty liver disease is associated with ventricular arrhythmias in patients with type 2 diabetes referred for clinically indicated 24-h holter monitoring","volume":"39","author":"Mantovani","year":"2016","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102580_bib0007","doi-asserted-by":"crossref","first-page":"59","DOI":"10.15403\/jgld-713","article-title":"Nonalcoholic fatty liver disease as a risk factor for prolonged corrected QT interval in apparently healthy Korean women","volume":"29","author":"Chung","year":"2020","journal-title":"J Gastrointest Liver Dis JGLD"},{"issue":"2","key":"10.1016\/j.cpcardiol.2024.102580_bib0008","doi-asserted-by":"crossref","first-page":"e57183","DOI":"10.1371\/journal.pone.0057183","article-title":"Non-alcoholic fatty liver disease is associated with an increased incidence of atrial fibrillation in patients with type 2 diabetes","volume":"8","author":"Targher","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.cpcardiol.2024.102580_bib0009","doi-asserted-by":"crossref","first-page":"483","DOI":"10.15403\/jgld-344","article-title":"Cardiac arrhythmias and electrocardiogram modifications in non-alcoholic fatty liver disease. A systematic review","volume":"28","author":"Ismaiel","year":"2019","journal-title":"J Gastrointestin Liver Dis"},{"key":"10.1016\/j.cpcardiol.2024.102580_bib0010","unstructured":"PRISMA [cited 2024 Jan 29]. Available from: http:\/\/prisma-statement.org\/PRISMAStatement\/Checklist."},{"key":"10.1016\/j.cpcardiol.2024.102580_bib0011","unstructured":"Study Quality Assessment Tools | NHLBI, NIH. [cited 2024 Feb 25]. Available from: https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools."},{"issue":"11","key":"10.1016\/j.cpcardiol.2024.102580_bib0012","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1002\/sim.1752","article-title":"Controlling the risk of spurious findings from meta-regression","volume":"23","author":"Higgins","year":"2004","journal-title":"Stat Med"},{"key":"10.1016\/j.cpcardiol.2024.102580_bib0013","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-230X-6-33","article-title":"The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"Bedogni","year":"2006","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"10.1016\/j.cpcardiol.2024.102580_bib0014","first-page":"284","article-title":"A preliminary report about the detection of ventricular repolarisation in patients with non-alcoholic fatty liver disease","volume":"15","author":"Al-Nimer","year":"2020","journal-title":"J Taibah Univ Med Sci"},{"issue":"7","key":"10.1016\/j.cpcardiol.2024.102580_bib0015","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.001820","article-title":"Nonalcoholic fatty liver disease is associated with QT prolongation in the general population","volume":"4","author":"Hung","year":"2015","journal-title":"J Am Heart Assoc"},{"issue":"21","key":"10.1016\/j.cpcardiol.2024.102580_bib0016","doi-asserted-by":"crossref","first-page":"14555","DOI":"10.3390\/ijerph192114555","article-title":"Nonalcoholic fatty liver disease is related to abnormal corrected QT interval and left ventricular hypertrophy in Chinese male steelworkers","volume":"19","author":"Hung","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"10.1016\/j.cpcardiol.2024.102580_bib0017","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1016\/j.ijcard.2013.07.035","article-title":"RBBB is associated with an increased risk of NAFLD in young healthy individuals","volume":"168","author":"\u0130\u015fcen","year":"2013","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.cpcardiol.2024.102580_bib0018","first-page":"375","article-title":"Clinical implications of cardiac symptoms and electrocardiographic abnormalities for advanced liver fibrosis in patients with nonalcoholic fatty liver disease","volume":"59","author":"Kang","year":"2023","journal-title":"Med Kaunas Lith"},{"issue":"11","key":"10.1016\/j.cpcardiol.2024.102580_bib0019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142937","article-title":"Non-alcoholic fatty liver disease as a predictor of atrial fibrillation in middle-aged population (OPERA study)","volume":"10","author":"K\u00e4r\u00e4j\u00e4m\u00e4ki","year":"2015","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.cpcardiol.2024.102580_bib0020","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1007\/s10620-019-05986-9","article-title":"Impact of NAFLD on the incidence of cardiovascular diseases in a primary care population in Germany","volume":"65","author":"Labenz","year":"2020","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102580_bib0021","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1038\/s41598-021-83367-x","article-title":"Nonalcoholic fatty liver disease and the risk of atrial fibrillation stratified by body mass index: a nationwide population-based study","volume":"11","author":"Lee","year":"2021","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.cpcardiol.2024.102580_bib0022","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.005227","article-title":"Relations of liver fat with prevalent and incident atrial fibrillation in the Framingham heart study","volume":"6","author":"Long","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.cpcardiol.2024.102580_bib0023","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/echo.14229","article-title":"Interatrial septal fat thickness and left atrial stiffness are mechanistic links between nonalcoholic fatty liver disease and incident atrial fibrillation","volume":"36","author":"Mahfouz","year":"2019","journal-title":"Echocardiogr Mt Kisco NY"},{"issue":"3","key":"10.1016\/j.cpcardiol.2024.102580_bib0024","first-page":"e1107","article-title":"Association of non-alcoholic fatty liver disease with conduction defects on electrocardiogram","volume":"9","author":"Mangi","year":"2017","journal-title":"Cureus"},{"issue":"10","key":"10.1016\/j.cpcardiol.2024.102580_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185459","article-title":"Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus","volume":"12","author":"Mantovani","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.cpcardiol.2024.102580_bib0026","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.atherosclerosis.2015.12.023","article-title":"Association between hepatic steatosis and serum liver enzyme levels with atrial fibrillation in the general population: The Study of Health in Pomerania (SHIP)","volume":"245","author":"Markus","year":"2016","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.cpcardiol.2024.102580_bib0027","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/clc.24015","article-title":"The association between nonalcoholic fatty liver disease and corrected QT interval prolongation among generally healthy Iranian population: Fasa cohort study (FACS)","volume":"46","author":"Naderi","year":"2023","journal-title":"Clin Cardiol"},{"issue":"3","key":"10.1016\/j.cpcardiol.2024.102580_bib0028","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/0161734615595015","article-title":"Doppler tissue evaluation of atrial conduction properties in patients with non-alcoholic fatty-liver disease","volume":"38","author":"Ozveren","year":"2016","journal-title":"Ultrason Imaging"},{"issue":"3","key":"10.1016\/j.cpcardiol.2024.102580_bib0029","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.mayocp.2019.08.027","article-title":"Prevalence and impact of nonalcoholic fatty liver disease in atrial fibrillation","volume":"95","author":"Pastori","year":"2020","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.cpcardiol.2024.102580_bib0030","first-page":"338","article-title":"Association between non-alcoholic fatty liver disease and risk of new-onset atrial fibrillation in healthy adults","volume":"40","author":"Roh","year":"2020","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"issue":"2","key":"10.1016\/j.cpcardiol.2024.102580_bib0031","doi-asserted-by":"crossref","first-page":"100","DOI":"10.5152\/AnatolJCardiol.2021.433","article-title":"Fragmented QRS in inferior leads is associated with non-alcholic fatty liver disease, body-mass index, and interventricular septum thickness in young men","volume":"26","author":"Sar\u0131kaya","year":"2022","journal-title":"Anatol J Cardiol"},{"key":"10.1016\/j.cpcardiol.2024.102580_bib0032","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jelectrocard.2020.05.008","article-title":"The prevalence and correlates of T-wave inversion in lead III in non-obese men","volume":"61","author":"Sengul","year":"2020","journal-title":"J Electrocardiol"},{"issue":"6","key":"10.1016\/j.cpcardiol.2024.102580_bib0033","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.numecd.2014.01.005","article-title":"Association of nonalcoholic fatty liver disease with QTc interval in patients with type 2 diabetes","volume":"24","author":"Targher","year":"2014","journal-title":"Nutr Metab Cardiovasc Dis NMCD"},{"issue":"4","key":"10.1016\/j.cpcardiol.2024.102580_bib0034","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jhep.2022.05.030","article-title":"Liver stiffness not fatty liver disease is associated with atrial fibrillation: the Rotterdam study","volume":"77","author":"van Kleef","year":"2022","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.cpcardiol.2024.102580_bib0035","first-page":"933","article-title":"Atrial fibrillation is highly prevalent yet undertreated in patients with biopsy-proven nonalcoholic steatohepatitis","volume":"39","author":"Whitsett","year":"2019","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"10.1016\/j.cpcardiol.2024.102580_bib0036","article-title":"Analysis of risk factors for adverse cardiovascular events in elderly patients with acute myocardial infarction and non-alcoholic fatty liver disease (NAFLD)","volume":"26","author":"Xia","year":"2020","journal-title":"Med Sci Monit Int Med J Exp Clin Res"},{"key":"10.1016\/j.cpcardiol.2024.102580_bib0037","article-title":"Nonalcoholic fatty liver disease is associated with increased atrial fibrillation risk in an elderly Chinese population: a cross-sectional study","volume":"2018","author":"Zhang","year":"2018","journal-title":"BioMed Res Int"},{"issue":"13_Supplement","key":"10.1016\/j.cpcardiol.2024.102580_bib0038","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0735-1097(16)30855-5","article-title":"Non-alcoholic fatty liver disease is independently associated with new onset atrial fibrillation: a nationwide cohort study in Korea","volume":"67","author":"You","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2024.102580_bib0039","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.1030968","article-title":"Association of non-alcoholic fatty liver disease with left ventricular changes in treatment-naive patients with uncomplicated hypertension","volume":"9","author":"Catena","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"24","key":"10.1016\/j.cpcardiol.2024.102580_bib0040","doi-asserted-by":"crossref","first-page":"12867","DOI":"10.3390\/ijerph182412867","article-title":"Low QRS voltage in limb leads indicates accompanying precordial voltage attenuation resulting in underestimation of left ventricular hypertrophy","volume":"18","author":"Gwag","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.cpcardiol.2024.102580_bib0041","doi-asserted-by":"crossref","first-page":"e9090","DOI":"10.7717\/peerj.9090","article-title":"Nonalcoholic fatty liver disease, a potential risk factor of non-specific ST-T segment changes: data from a cross-sectional study","volume":"8","author":"Xiao","year":"2020","journal-title":"PeerJ"},{"issue":"6","key":"10.1016\/j.cpcardiol.2024.102580_bib0042","first-page":"661","article-title":"Association between cardiac conduction defect and nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"33","author":"Wijarnpreecha","year":"2020","journal-title":"Ann Gastroenterol"},{"issue":"2","key":"10.1016\/j.cpcardiol.2024.102580_bib0043","first-page":"143","article-title":"Increased P wave dispersion in patients with liver steatosis","volume":"7","author":"Aparci","year":"2010","journal-title":"Med Glas Off Publ Med Assoc Zenica-Doboj Cant Bosnia Herzeg"},{"key":"10.1016\/j.cpcardiol.2024.102580_bib0044","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.2147\/DMSO.S263093","article-title":"The association of metabolic syndrome and its components with electrocardiogram parameters and abnormalities among an Iranian rural population: the Fasa PERSIAN cohort study","volume":"13","author":"Yazdanpanah","year":"2020","journal-title":"Diabetes Metab Syndr Obes Targets Ther"},{"issue":"8","key":"10.1016\/j.cpcardiol.2024.102580_bib0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0237360","article-title":"Association of worsening of nonalcoholic fatty liver disease with cardiometabolic function and intestinal bacterial overgrowth: a cross-sectional study","volume":"15","author":"Lira","year":"2020","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.cpcardiol.2024.102580_bib0046","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000365012","article-title":"Electrocardiological features in obesity: the benefits of body surface potential mapping","volume":"4","author":"Simonyi","year":"2014","journal-title":"Cardiorenal Med"},{"issue":"21","key":"10.1016\/j.cpcardiol.2024.102580_bib0047","doi-asserted-by":"crossref","first-page":"e984","DOI":"10.1161\/CIR.0000000000000973","article-title":"Obesity and cardiovascular disease: a scientific statement from the American Heart Association","volume":"143","author":"Powell-Wiley","year":"2021","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.cpcardiol.2024.102580_bib0048","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1113\/JP273043","article-title":"Hypertension-induced remodelling: on the interactions of cardiac risk factors","volume":"595","author":"Tomek","year":"2017","journal-title":"J Physiol"},{"issue":"17","key":"10.1016\/j.cpcardiol.2024.102580_bib0049","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.3390\/ijerph16173104","article-title":"Cardiovascular risk in non-alcoholic fatty liver disease: mechanisms and therapeutic implications","volume":"16","author":"Tana","year":"2019","journal-title":"Int J Environ Res Public Health"},{"issue":"6","key":"10.1016\/j.cpcardiol.2024.102580_bib0050","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.3390\/antiox12061172","article-title":"From obesity-induced low-grade inflammation to lipotoxicity and mitochondrial dysfunction: altered multi-crosstalk between adipose tissue and metabolically active organs","volume":"12","author":"Cavaliere","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.cpcardiol.2024.102580_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101238","article-title":"Metabolic-associated fatty liver disease and lipoprotein metabolism","volume":"50","author":"Heeren","year":"2021","journal-title":"Mol Metab"},{"issue":"5","key":"10.1016\/j.cpcardiol.2024.102580_bib0052","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.3390\/nu5051544","article-title":"Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease","volume":"5","author":"Gaggini","year":"2013","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102580_bib0053","first-page":"9","article-title":"Non alcoholic fatty liver disease and metabolic syndrome","volume":"13","author":"Paschos","year":"2009","journal-title":"Hippokratia"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280624002196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280624002196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T02:11:23Z","timestamp":1716948683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280624002196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":53,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0146280624002196"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2024.102580","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Electrocardiographic abnormalities in patients with metabolic dysfunction-associated steatotic liver disease: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2024.102580","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102580"}}